Evolent Health (EVH) Invested Capital (2020 - 2025)

Evolent Health's Invested Capital history runs 5 years deep, the most recent figure standing at $5.1 million for Q3 2025.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $5.1 million in Q3 2025; TTM through Mar 2026 was $177.2 million, a 48.37% decrease from a year earlier, with the FY2024 full-year figure at $171.5 million, changed N/A from the prior year.
• Invested Capital fell to $5.1 million in Q3 2025 per EVH's latest filing, from $172.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $172.1 million in Q2 2025 and bottomed at $991000.0 in Q3 2023.
• The 4-year median for Invested Capital is $26.7 million (2021), against an average of $75.2 million.